Snowball logo
logo
CASI

CASI Pharmaceuticals Inc

CASI β€’ NASDAQ
$0.207$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20202021202220232024TTM
Revenue
Total revenue
15.1430.1743.1133.8828.5426.85
COGS
9.50812.5615.8313.8317.3917.23
Gross Profit
5.63317.6127.2820.0511.159.611
Operating Expenses & Income
Operating Income
(52.78)(41.52)(26.49)(25.08)(39.62)(45.09)
Total Operating Expenses
58.4159.1353.7745.1350.7754.71
R&D Expenses
11.4714.42169.8618.9178.739
Selling General & Admin Expenses
19.6623.723.4525.3923.5825.83
Earnings from Continuing Operations
Interest Expense
-(5.995)(0.062)(0.015)(0.871)(1.33)
Interest Income
0.8660.3210.1270.6140.5390.132
Income Tax Expense
15.061.931.98(0.081)1.1892.247
Net Income
Net Income
(48.29)(36.65)(41.01)(26.94)(39.26)(49.38)
Supplemental
EBIT
(33.31)(35.22)(26.49)(25.28)(37.2)-
EBITDA
(31.35)(33.4)(24.07)(21.54)(34.87)(41.37)
In millions of USD, except % and values per 1 share